Literature DB >> 35005072

Disappearance of Clinical and Imaging Manifestations in Wilson's Disease with Ammonium Tetrathiomolybdate and Zinc.

Ignacio J Posada1, Ana Ramos2.   

Abstract

Entities:  

Keywords:  Wilson's disease; ceruloplasmin; penicillamine; tetrathiomolybdate

Year:  2021        PMID： 35005072      PMCID： PMC8721833          DOI： 10.1002/mdc3.13359

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  7 in total

Review 1.  Clinical considerations for an effective medical therapy in Wilson's disease.

Authors:  Karl Heinz Weiss; Wolfgang Stremmel
Journal:  Ann N Y Acad Sci       Date:  2014-04-22       Impact factor: 5.691

Review 2.  Wilson Disease: An Overview and Approach to Management.

Authors:  Caitlin Mulligan; Jeff M Bronstein
Journal:  Neurol Clin       Date:  2020-02-28       Impact factor: 3.806

3.  Use of ammonium tetrathiomolybdate in the treatment of copper poisoning in sheep.

Authors:  W R Humphries; C F Mills; A Greig; L Roberts; D Inglis; G J Halliday
Journal:  Vet Rec       Date:  1986-12-13       Impact factor: 2.695

4.  A novel Global Assessment Scale for Wilson's Disease (GAS for WD).

Authors:  Annu Aggarwal; Nitin Aggarwal; Aabha Nagral; Govindji Jankharia; Mohit Bhatt
Journal:  Mov Disord       Date:  2009-03-15       Impact factor: 10.338

5.  Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy.

Authors:  George J Brewer; Peter Hedera; Karen J Kluin; Martha Carlson; Fred Askari; Robert B Dick; Julia Sitterly; John K Fink
Journal:  Arch Neurol       Date:  2003-03

Review 6.  Advances in Treatment of Wilson Disease.

Authors:  Annu Aggarwal; Mohit Bhatt
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2018-02-28

7.  Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series.

Authors:  Oriol De Fabregues; Jaume Viñas; Antoni Palasí; Manuel Quintana; Ignasi Cardona; Cristina Auger; Víctor Vargas
Journal:  Brain Behav       Date:  2020-03-22       Impact factor: 2.708
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.